Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Discogenic Back Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* MR imaging : MODIC 1or MODIC 2 changes limited to one single lumbar disc;~* X rays: normal disc height, no instability;~* Back pain for at least 3 months, without argument for another etiology;~* Mean pain on 5 days VAS ≥ 5~Exclusion Criteria:~* age \<18 years or \> 50 ; concomitant radicular pain ;~* psychiatric pathology that may modify the perception or the evolution of pain;~* MR imaging: multi-level discopathy, MODIC 3 changes;~* X ray: loss of disc height \> 50%, segmental instability;~* previous history of lumbar surgery with or without instrumentation.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- DISCOGEL (Type: EXPERIMENTAL): Percutaneous intradiscal injection of Discogel
- conventional treatment (Type: ACTIVE_COMPARATOR): conventional treatment based on current guidelines regarding the management of discogenic low back pain, including but not limited to: medications (analgesics, NSAIDs, muscle relaxants), physical therapy, manual techniques, transcutaneous electrical nerve stimulation (TENS), blocks

Based on this trial design, predict the completion outcome and termination type (if applicable).